{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/psychosis-schizophrenia/","result":{"data":{"firstChapter":{"id":"d60310a0-752b-5399-8488-a567bf6a3925","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 7720f733-51d2-4ccb-b951-b96ded5beb82 --><h1>Psychosis and schizophrenia: Summary</h1><!-- end field 7720f733-51d2-4ccb-b951-b96ded5beb82 -->","htmlStringContent":"<!-- begin item 9f37ffb9-89b0-4fb6-93d6-572ffe0e6cd2 --><!-- begin field 5f3de8a2-8c09-40b5-a9eb-7859da4cf132 --><ul><li>The term 'psychosis' encompasses a number of symptoms associated with significant alternations to a person's perception, thoughts, mood, and behaviour.</li><li>Individuals experiencing psychosis will have a different combination of symptoms, which may include:<ul><li>Positive symptoms — disorganised behaviour, speech, and/or thoughts (thought disturbance), delusions (fixed or falsely-held beliefs), and/or hallucinations (perceptions in the absence of stimulus). </li><li>Negative symptoms — emotional blunting, reduced speech, loss of motivation, self-neglect, social withdrawal.</li></ul></li><li>Psychotic symptoms are cardinal features of psychotic disorders, the most common of which is schizophrenia, but may also be caused acutely by certain medicines, substance misuse, and by some medical conditions such as sepsis.</li><li>With treatment, psychotic symptoms as a feature of a psychotic disorder may resolve fully, recur intermittently with periods of remission between, or persist.</li><li>Complications of psychotic disorders include:<ul><li>An increased risk of premature death due higher rates of suicide, cardiovascular disease, and type 2 diabetes.</li><li>Difficulties in social functioning.</li><li>Substance misuse.</li></ul></li><li>A prodromal period of emotional disturbance may precede the development of a psychotic disorder. A person may be in the prodromal period if they exhibit distress and/or a deterioration in social functioning, and:<ul><li>Transient (short duration) or attenuated (low intensity) psychotic symptoms, <em>or</em></li><li>Other experiences or behaviour suggestive of possible psychosis (for example, suspicion, mistrust, or perceptual changes), <em>or</em></li><li>A first-degree relative with a psychotic disorder.</li></ul></li><li>People at risk of developing a psychotic disorder and people with psychotic symptoms should be assessed to determine their risk of harm to themselves and others:<ul><li>If there is a high risk of harm, same-day mental health assessment by the early intervention in psychosis service should ideally be arranged. If this service is not available, is unable to provide urgent intervention, or the level of risk exceeds the management capacity of the early intervention in psychosis service, the person should be referred to a crisis resolution and home treatment team.</li><li>If a person with psychosis is not judged to be at high risk of harm, they should be referred without delay to the early intervention in psychosis service. If the service cannot provide urgent intervention, the person should be referred to the crisis resolution and home treatment team.</li><li>If a person suspected to be in the prodromal phase of psychosis is not judged to be at high risk of harm, they should be referred without delay refer to the early intervention in psychosis service (if available) or a specialist mental health service. A consultant psychiatrist or a trained specialist with experience in at-risk mental states should carry out an assessment.</li><li>An antipsychotic drug should not be given to the person while awaiting specialist assessment, unless under advice from a consultant psychiatrist.</li></ul></li><li>For people who are at risk of developing a psychotic disorder, specialist mental health services will usually offer treatment with individual cognitive behavioural therapy (CBT) with or without family intervention.</li><li>For people with a diagnosed psychotic disorder, specialist mental health services will usually offer a therapeutic trial of an oral antipsychotic in conjunction with family intervention, individual CBT, or arts therapy.</li><li>For people with an established diagnosis of a psychotic disorder who relapse, a risk assessment of harm to the person or others should be carried out:<ul><li>A person with a treatment care plan should be managed according to the plan.</li><li>A person without a care plan who is judged to be at immediate risk of harm should be referred for same-day specialist assessment to the local crisis resolution and home treatment team.</li><li>A person without a care plan not judged not to be at immediate risk of harm should be referred to the community mental health service.</li></ul></li><li>The secondary care team should maintain responsibility for monitoring the person's physical health and the effects of any antipsychotic medication for the first 12 months of treatment, or until the person's condition has stabilised (whichever is the longest). After this, the responsibility for monitoring may be transferred to primary care, depending on locally agreed shared care guidelines or the person's care plan.</li></ul><!-- end field 5f3de8a2-8c09-40b5-a9eb-7859da4cf132 --><!-- end item 9f37ffb9-89b0-4fb6-93d6-572ffe0e6cd2 -->","topic":{"id":"9b90da89-2ffd-5b6a-9fc6-ea342404d5d8","topicId":"fd02ebc3-0f02-42b5-8737-e0608ca4330d","topicName":"Psychosis and schizophrenia","slug":"psychosis-schizophrenia","aliases":["Schizophrenia and psychosis"],"chapters":[{"id":"d60310a0-752b-5399-8488-a567bf6a3925","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"10869ad6-510d-54db-bc6a-ce3618a1c478","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"1025e31f-c89d-5344-b4ae-d5e8950a5c0e","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"594160f5-1a9b-56f0-952c-5c400ea28785","slug":"changes","fullItemName":"Changes"},{"id":"e20c0ce8-30f6-5e09-81d1-3e6005f85efe","slug":"update","fullItemName":"Update"}]},{"id":"4c4f0990-85fa-5fc4-9a58-9f02a868a971","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"02637a5f-4552-5e73-9245-cf480497e9a5","slug":"goals","fullItemName":"Goals"},{"id":"8c88de52-9655-52d8-b302-67641ae05beb","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c6754da2-fd29-5d45-8097-40b8ec0589cd","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"31a210b8-403b-5530-b1ea-0b44a2595f07","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c5630117-b04c-558a-b516-41c3eab9adbd","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"e9e078fd-a616-51bf-944f-2efbb2a01feb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"99d1cff5-adca-5573-9fa8-58c2e9f937e0","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"23ac3781-557a-57b8-95b5-83db37a53fda","slug":"definition","fullItemName":"Definition"},{"id":"3e7238cc-23d8-56f6-a8af-255ed6a876d7","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"9576e7c9-3a1e-57d3-bb86-a4e5e10462e1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b79b29b0-d7ad-5bad-87fd-e5a48ced5427","slug":"course-prognosis","fullItemName":"Course and prognosis"},{"id":"598444d7-6337-5133-a088-176b1f83ab01","slug":"complications","fullItemName":"Complications"}]},{"id":"a913b80f-eec4-5c47-9d9c-0b20f4648b73","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"e7897095-2be8-5df7-a7e3-c1060d4a453a","slug":"identifying-someone-at-risk-of-a-psychotic-disorder-or-experiencing-their-first-episode-of-psychosis","fullItemName":"Identifying someone at risk of a psychotic disorder or experiencing their first episode of psychosis"},{"id":"a8f36210-9cb6-590b-8e3d-7ddbc6d31e88","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f86ff69c-c33e-5b8c-affa-04759f25bf5a","slug":"management","fullItemName":"Management","subChapters":[{"id":"34c0807e-9463-536b-9ff4-c3537046a6ba","slug":"primary-care-management","fullItemName":"Scenario: Primary care management"},{"id":"468f8b6f-bc79-5ecd-b1c2-d7ff27721abe","slug":"managing-relapse","fullItemName":"Scenario: Managing relapse"},{"id":"30f16f24-0127-53b7-bd08-c679a189090b","slug":"the-routine-schizophrenia-or-psychosis-review","fullItemName":"Scenario: The routine schizophrenia or psychosis review"},{"id":"c20919b9-2e4c-5c56-b3cd-7fb432199a8b","slug":"women-of-childbearing-age","fullItemName":"Scenario: Women of childbearing age"}]},{"id":"a9fe56bb-7ae3-5523-b0e2-5b7da5aa8439","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"f78f8497-f98b-5445-82fe-23a4ced38576","slug":"available-antipsychotics","fullItemName":"Available antipsychotics"},{"id":"05e42d64-ee5a-5c2b-8817-5fc77abb19ec","slug":"adverse-effects","fullItemName":"Adverse effects"},{"id":"25b3e7d5-bc3d-5749-9304-a717c1f4e386","slug":"interactions","fullItemName":"Interactions"},{"id":"ed339043-f5e2-5209-9ba0-cb06890e1050","slug":"monitoring","fullItemName":"Monitoring"}]},{"id":"7ae82132-000d-507c-b73d-542c43656041","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"1bf0a6af-76cf-5f6b-b7fb-4c746ff0f413","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"49b46ed4-7209-5c01-b07f-54117f9ad3c0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a4647644-8726-5bfc-b471-6e157c3f10a3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a31ae673-4520-58d5-95ee-db2395fb5238","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3beebe4c-a826-5b46-a8cd-a97fe8ec3b8b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"aaaadecf-036b-531f-a8bf-75fccd84219f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"49078833-deae-54f3-ad89-562370e4d181","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"9b90da89-2ffd-5b6a-9fc6-ea342404d5d8","topicId":"fd02ebc3-0f02-42b5-8737-e0608ca4330d","topicName":"Psychosis and schizophrenia","slug":"psychosis-schizophrenia","aliases":["Schizophrenia and psychosis"],"topicSummary":"Psychosis is a disordered mental state characterized principally by positive symptoms such as hallucinations, delusions, and thought disorder.","lastRevised":"Last revised in November 2020","nextPlannedReviewBy":"2025-01-01T00:00:00+00:00","nextPlannedReviewByDateTime":"2025-01","nextPlannedReviewByDisplay":"January 2025","specialities":[{"id":"460cf76a-c057-55d8-a7ab-50fe9463f7da","name":"Mental health","slug":"mental-health"}],"chapters":[{"id":"d60310a0-752b-5399-8488-a567bf6a3925","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"10869ad6-510d-54db-bc6a-ce3618a1c478","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"1025e31f-c89d-5344-b4ae-d5e8950a5c0e","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"594160f5-1a9b-56f0-952c-5c400ea28785","slug":"changes","fullItemName":"Changes"},{"id":"e20c0ce8-30f6-5e09-81d1-3e6005f85efe","slug":"update","fullItemName":"Update"}]},{"id":"4c4f0990-85fa-5fc4-9a58-9f02a868a971","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"02637a5f-4552-5e73-9245-cf480497e9a5","slug":"goals","fullItemName":"Goals"},{"id":"8c88de52-9655-52d8-b302-67641ae05beb","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c6754da2-fd29-5d45-8097-40b8ec0589cd","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"31a210b8-403b-5530-b1ea-0b44a2595f07","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"c5630117-b04c-558a-b516-41c3eab9adbd","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"e9e078fd-a616-51bf-944f-2efbb2a01feb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"99d1cff5-adca-5573-9fa8-58c2e9f937e0","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"23ac3781-557a-57b8-95b5-83db37a53fda","slug":"definition","fullItemName":"Definition"},{"id":"3e7238cc-23d8-56f6-a8af-255ed6a876d7","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"9576e7c9-3a1e-57d3-bb86-a4e5e10462e1","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b79b29b0-d7ad-5bad-87fd-e5a48ced5427","slug":"course-prognosis","fullItemName":"Course and prognosis"},{"id":"598444d7-6337-5133-a088-176b1f83ab01","slug":"complications","fullItemName":"Complications"}]},{"id":"a913b80f-eec4-5c47-9d9c-0b20f4648b73","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"e7897095-2be8-5df7-a7e3-c1060d4a453a","slug":"identifying-someone-at-risk-of-a-psychotic-disorder-or-experiencing-their-first-episode-of-psychosis","fullItemName":"Identifying someone at risk of a psychotic disorder or experiencing their first episode of psychosis"},{"id":"a8f36210-9cb6-590b-8e3d-7ddbc6d31e88","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f86ff69c-c33e-5b8c-affa-04759f25bf5a","slug":"management","fullItemName":"Management","subChapters":[{"id":"34c0807e-9463-536b-9ff4-c3537046a6ba","slug":"primary-care-management","fullItemName":"Scenario: Primary care management"},{"id":"468f8b6f-bc79-5ecd-b1c2-d7ff27721abe","slug":"managing-relapse","fullItemName":"Scenario: Managing relapse"},{"id":"30f16f24-0127-53b7-bd08-c679a189090b","slug":"the-routine-schizophrenia-or-psychosis-review","fullItemName":"Scenario: The routine schizophrenia or psychosis review"},{"id":"c20919b9-2e4c-5c56-b3cd-7fb432199a8b","slug":"women-of-childbearing-age","fullItemName":"Scenario: Women of childbearing age"}]},{"id":"a9fe56bb-7ae3-5523-b0e2-5b7da5aa8439","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"f78f8497-f98b-5445-82fe-23a4ced38576","slug":"available-antipsychotics","fullItemName":"Available antipsychotics"},{"id":"05e42d64-ee5a-5c2b-8817-5fc77abb19ec","slug":"adverse-effects","fullItemName":"Adverse effects"},{"id":"25b3e7d5-bc3d-5749-9304-a717c1f4e386","slug":"interactions","fullItemName":"Interactions"},{"id":"ed339043-f5e2-5209-9ba0-cb06890e1050","slug":"monitoring","fullItemName":"Monitoring"}]},{"id":"7ae82132-000d-507c-b73d-542c43656041","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"1bf0a6af-76cf-5f6b-b7fb-4c746ff0f413","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"49b46ed4-7209-5c01-b07f-54117f9ad3c0","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a4647644-8726-5bfc-b471-6e157c3f10a3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"a31ae673-4520-58d5-95ee-db2395fb5238","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3beebe4c-a826-5b46-a8cd-a97fe8ec3b8b","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"aaaadecf-036b-531f-a8bf-75fccd84219f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"49078833-deae-54f3-ad89-562370e4d181","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"9b90da89-2ffd-5b6a-9fc6-ea342404d5d8"}},"staticQueryHashes":["3666801979"]}